MED EIBY Holding Co., Limited (BSME)

MED EIBY Holding Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2022	Jun 30, 2021
Revenue	3.39	3.39	2.78
Revenue Growth (YoY)	-	22.00%	-
Cost of Revenue	2.6	2.6	2.2
Gross Profit	0.79	0.79	0.57
Selling, General & Admin	2.49	2.49	1.33
Research & Development	0.41	0.41	0.44
Operating Expenses	2.9	2.9	1.78
Operating Income	-2.11	-2.11	-1.21
Interest Expense / Income	0.11	0.11	0.1
Other Expense / Income	-0.07	-0.07	0.2
Pretax Income	-2.15	-2.15	-1.51
Income Tax	0.18	0.18	-0.17
Net Income	-2.33	-2.33	-1.34
Free Cash Flow	-1.46	-1.46	-1.07
Gross Margin	23.30%	23.30%	20.58%
Operating Margin	-62.35%	-62.35%	-43.43%
Profit Margin	-68.70%	-68.70%	-48.13%
Free Cash Flow Margin	-43.10%	-43.10%	-38.63%
EBITDA	-1.99	-1.99	-1.37
EBITDA Margin	-58.90%	-58.90%	-49.32%
Depreciation & Amortization	0.05	0.05	0.04
EBIT	-2.04	-2.04	-1.41
EBIT Margin	-60.29%	-60.29%	-50.80%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).